Multiple Myeloma Unpacked

被引:0
作者
Gay, Francesca [1 ]
Marchetti, Edoardo [1 ]
Bertuglia, Giuseppe [1 ]
机构
[1] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Div Hematol, AOU Citta Salute & Sci, Turin, Italy
关键词
immunotherapies; myeloma; response assessment; staging; TRANSPLANT-INELIGIBLE PATIENTS; DARATUMUMAB PLUS LENALIDOMIDE; INTERNATIONAL STAGING SYSTEM; NDMM UPDATED ANALYSIS; T-CELL THERAPY; OPEN-LABEL; CILTACABTAGENE AUTOLEUCEL; DEXAMETHASONE; CARFILZOMIB; BORTEZOMIB;
D O I
10.1002/hon.70067
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multiple myeloma (MM) is a hematologic malignancy characterized by the clonal proliferation of plasma cells in the bone marrow. The current treatment landscape for multiple myeloma involves a combination of proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, and autologous stem cell transplantation, which have significantly improved survival outcomes in recent years. However, the disease remains challenging, particularly in relapsed and refractory cases. Ongoing clinical trials are evaluating new therapeutic options, including chimeric antigen receptor T cell therapy, bispecific antibodies, antibody drug conjugate and novel agents like Cereblon E3 Ligase Modulatory Drugs. This review summarizes the key diagnostic criteria, prognostic features, response assessment for MM and highlights the current treatment landscape.
引用
收藏
页数:14
相关论文
共 97 条
[51]   Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma [J].
Lonial, Sagar ;
Jacobus, Susanna ;
Fonseca, Rafael ;
Weiss, Matthias ;
Kumar, Shaji ;
Orlowski, Robert Z. ;
Kaufman, Jonathan L. ;
Yacoub, Abdulraheem M. ;
Buadi, Francis K. ;
O'Brien, Timothy ;
Matous, Jeffrey V. ;
Anderson, Daniel M. ;
Emmons, Robert V. ;
Mahindra, Anuj ;
Wagner, Lynne I. ;
Dhodapkar, Madhav V. ;
Rajkumar, S. Vincent .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (11) :1126-+
[52]   Prevention of infections including vaccination strategies in multiple myeloma [J].
Ludwig, Heinz ;
Kumar, Shaji .
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 :S46-S62
[53]   Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial [J].
Mai, Elias K. ;
Bertsch, Uta ;
Pozek, Ema ;
Fenk, Roland ;
Besemer, Britta ;
Hanoun, Christine ;
Schroers, Roland ;
von Metzler, Ivana ;
Haenel, Mathias ;
Mann, Christoph ;
Leypoldt, Lisa B. ;
Heilmeier, Bernhard ;
Huhn, Stefanie ;
Vogel, Sabine K. ;
Hundemer, Michael ;
Scheid, Christof ;
Blau, Igor W. ;
Luntz, Steffen ;
Weinhold, Niels ;
Tichy, Diana ;
Holderried, Tobias A. W. ;
Trautmann-Grill, Karolin ;
Gezer, Deniz ;
Klaiber-Hakimi, Maika ;
Mueller, Martin ;
Shumilov, Evgenii ;
Knauf, Wolfgang ;
Michel, Christian S. ;
Geer, Thomas ;
Riesenberg, Hendrik ;
Lutz, Christoph ;
Raab, Marc S. ;
Benner, Axel ;
Hoffmann, Martin ;
Weisel, Katja C. ;
Salwender, Hans J. ;
Goldschmidt, Hartmut .
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (11) :1279-1288
[54]  
Manier S, 2024, BLOOD, V144, P776, DOI [10.1182/blood-2024-203045, 10.1182/blood-2024-203045]
[55]   Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma [J].
Mateos, M. -V. ;
Dimopoulos, M. A. ;
Cavo, M. ;
Suzuki, K. ;
Jakubowiak, A. ;
Knop, S. ;
Doyen, C. ;
Lucio, P. ;
Nagy, Z. ;
Kaplan, P. ;
Pour, L. ;
Cook, M. ;
Grosicki, S. ;
Crepaldi, A. ;
Liberati, A. M. ;
Campbell, P. ;
Shelekhova, T. ;
Yoon, S. -S. ;
Iosava, G. ;
Fujisaki, T. ;
Garg, M. ;
Chiu, C. ;
Wang, J. ;
Carson, R. ;
Crist, W. ;
Deraedt, W. ;
Nguyen, H. ;
Qi, M. ;
San-Miguel, J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (06) :518-528
[56]   Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Alcyone Study [J].
Mateos, Maria-Victoria ;
San-Miguel, Jesus ;
Cavo, Michele ;
Creixenti, Joan Blade ;
Suzuki, Kenshi ;
Jakubowiak, Andrzej ;
Knop, Stefan ;
Doyen, Chantal ;
Lucio, Paulo ;
Nagy, Zsolt ;
Pour, Ludek ;
Grosicki, Sebastian ;
Crepaldi, Andre H. ;
Liberati, Anna Marina ;
Campbell, Philip ;
Shelekhova, Tatiana ;
Yoon, Sung-Soo ;
Iosava, Genadi ;
Fujisaki, Tomoaki ;
Garg, Mamta ;
Pei, Huiling ;
Krevvata, Maria ;
Carson, Robin ;
Borgsten, Fredrik ;
Dimopoulos, Meletios A. .
BLOOD, 2022, 140 :10157-10159
[57]  
Mateos MV, 2022, J CLIN ONCOL, V40
[58]   Original Research Lenalidomide-dexamethasone versus observation in high-risk smoldering myeloma after 12 years of median follow-up time: A randomized, open-label study* [J].
Mateos, Maria-Victoria ;
Hernandez, Miguel-Teodoro ;
Salvador, Carlos ;
de la Rubia, Javier ;
de Arriba, Felipe ;
Lopez-Corral, Lucia ;
Rosinol, Laura ;
Paiva, Bruno ;
Palomera, Luis ;
Bargay, Joan ;
Oriol, Albert ;
Prosper, Felipe ;
Lopez, Javier ;
Arguinano, Jose-Maria ;
Blade, Joan ;
Lahuerta, Juan-Jose ;
San-Miguel, Jesus .
EUROPEAN JOURNAL OF CANCER, 2022, 174 :243-250
[59]   International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM) [J].
Mateos, Maria-Victoria ;
Kumar, Shaji ;
Dimopoulos, Meletios A. ;
Gonzalez-Calle, Veronica ;
Kastritis, Efstathios ;
Hajek, Roman ;
Fernandez De Larrea, Carlos ;
Morgan, Gareth J. ;
Merlini, Giampaolo ;
Goldschmidt, Hartmut ;
Geraldes, Catarina ;
Gozzetti, Alessandro ;
Kyriakou, Charalampia ;
Garderet, Laurent ;
Hansson, Markus ;
Zamagni, Elena ;
Fantl, Dorotea ;
Leleu, Xavier ;
Kim, Byung-Su ;
Esteves, Graca ;
Ludwig, Heinz ;
Usmani, Saad ;
Min, Chang-Ki ;
Qi, Ming ;
Ukropec, Jon ;
Weiss, Brendan M. ;
Rajkumar, S. Vincent ;
Durie, Brian G. M. ;
San-Miguel, Jesus .
BLOOD CANCER JOURNAL, 2020, 10 (10)
[60]   Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma [J].
Mateos, Maria-Victoria ;
Hernandez, Miguel-Teodoro ;
Giraldo, Pilar ;
de la Rubia, Javier ;
de Arriba, Felipe ;
Lopez Corral, Lucia ;
Rosinol, Laura ;
Paiva, Bruno ;
Palomera, Luis ;
Bargay, Joan ;
Oriol, Albert ;
Prosper, Felipe ;
Lopez, Javier ;
Olavarria, Eduardo ;
Quintana, Nuria ;
Garcia, Jose-Luis ;
Blade, Joan ;
Lahuerta, Juan-Jose ;
San Miguel, Jesus-F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (05) :438-447